Abstract:Objective To evaluate the efficacy and safety of beclometasone dipropionate aqueous nasal spray in the treatment of allergic rhinitis.Methods This is a multieenter,randomized,doubleblind,and positive drug parallel controlled clinical trial.The patients with allergic rhinitis and who met the eligibility criteria were enrolled and divided into the test group and the control group.The patients in the test group received beclometasone dipropionate aqueous nasal spray and the patients in the control group received beclometasone dipropionate nasal spray.All patients in the 2 groups were administered two inhalations of beclomethasone dipropionate into each nostril twice daily(each inhalation contains beclometasone dipropionate 50 μg) for 14 days.The efficacy of these two drugs was evaluated according to the total scores of symptoms of rhinitis,scores of signs and quality of life and percentage changes of patients in three scores mentioned above when the treatment was over.The safety of these two drugs was evaluated according to the incidence of adverse events/adverse reactions,the results of laboratory tests,and ECG when the treatment was over.Results A total of 239 patients were included into the efficacy analysis.Of them,120 patients were in the test group and 119 were in the control group.There was no significant differences in gender, age,rhinitis symptoms,and signs before the drug administration between the 2 groups(P>0.05).The total scores of symptoms of rhinitis,scores of signs and quality of life on days 7 and 14 of treatment decreased significantly as compared with those obtained before the treatment in the both groups(P<0.05), but there was no significant difference in the extent of decrease between the 2 groups(P>0.05).When the treatments were over,the differences in the percentage changes of patients of rhinitis symptoms,signs and quality of life scores before and after treatments in the both 2 groups were statistically significant(P< 0.05),but there was no significant difference between the 2 groups(P>0.05).A total of 241 patients were included into the safety analysis.Of them,121 patients were in the test group and 120 were in the control group.There were 12 adverse events in 10 patients in the test group.Of them,2 events in the 2 patients were adverse drug reactions,including 1 case with throat discomfort and another case with nose bleeding.There were 20 adverse events in the 13 patients in the control group.Of them,11 events in 7 patients were adverse drug reactions and nose bleeding and dry nose were their major manifestations.There was no significant difference in the incidence of adverse events between the 2 groups(P>0.05).No severe adverse events occurred during the clinical trial.Conclusion Beclometasone dipropionate aqueous nasal spray could effectively control the symptoms of allergic rhinitis and its efficacy and safety were similar to those of beclometasone dipropionate nasal spray.

Efficacy and safety of pemirolast potassium in comparison with tranilast for bronchial asthma and allergic rhinitis:a multicenter,randomized,double-blind,double-dummy,parallel-group trial

Curative Effect and Security of Pidotimod Oral Liquid on the Prevention and Treatment of Childhood with Asthma

Efficacy and safety of beclometasone dipropionate aqueous nasal spray in the treatment of allergic rhinitis:a multicenter,randomized,double-blind,and controlled trial

Efficacy and Safety of Mizolastine in the Treatment of Perennial Allergic Rhinitis

Efficacy of formoterol in asthma: a multicenter, double-blind and randomized study

Multicenter Randomized Controlled Clinical Trial of Mabuterol Hydrochloride Tablets Versus Procaterol Hydrochloride in the Treatment of Bronchial Asthma

Efficacy and Safety of Budesonide/formoterol Single Inhaler Therapy Versus Budesonide Inhaler Plus Formoterol Inhaler in Asthma Patients

Efficacy and Safety of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray in Treating Allergic Rhinitis: a Randomized Controlled Trial

Randomized Double-Blind Control Multicenter Clinical Study of Levalbuterol Hydrochloride in the Treament of Mild-Moderate Asthma

Azelastine nasal spray in treating perennial allergic rhinitis: a randomly double-blind trial

Evaluation of the Efficacy of Olopatadine Hydrochloride in the Treating Allergic Rhinitis:A Multicenter,Randomized,Double-blind,Double-dummy Study

Randomized Controlled Clinical Trial Comparing Budesonide Plus Montelukast and Loratadine Plus Montelukast for Treatment of Moderate and Severe Persistent Allergic Rhinitis

A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic Rhinitis

Randomized Controlled Clinical Trial on Azelastine Hydrochloride Tablet Versus Loratadine in the Treatment of Allergic Rhinitis

Efficacy and safety of mepolizumab in a Chinese population with severe asthma: a phase III, randomised, double-blind, placebo-controlled trial

A Comparative Study of Montelukast and Azelastine add on Therapy in Moderate to Severe Allergic Rhinitis Treatment: A Double-Blind Randomized Clinical Trial

A Multicenter Randomized Double-Blind 2-Week Comparison Study of Azelastine Nasal Spray 0.1% Versus Levocabastine Nasal Spray 0.05% in Patients with Moderate-to-severe Allergic Rhinitis.

Comparison of the Effects of Salmeterol/fluticasone Versus Fluticasone over 1-Year on Small Airway Functions in Asthmatics

Efficacy and Safety of Montelukast in Treatment of Acute Asthma in Adults:A Systematic Review

Comparison of the Efficacy and Safety of Bilastine 20 mg versus Fexofenadine 180 mg for Treatment of Perennial Allergic Rhinitis: Randomized Controlled Study

Clinical efficacy and safety of MP-AzeFlu for the treatment of allergic rhinitis: a meta-analysis